Clinical Trial Update: Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of DW0929 in patients with hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• DW0929

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED